Medium materiality6/10
Tandem Diabetes price target lowered to $18 from $20 at Mizuho
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
TNDM price target lowered to $18 from $20 at Mizuho Securities. Current price: $16.45.
- Target $18; current price $16.45; Mizuho Securities.
Key facts
- 01
Target: $18
- 02
Posted price: $16.45
- 03
Analyst firm: Mizuho Securities
- 04
Analyst: Anthony Petrone
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.